Korean Chinese Japanese
  • Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Korean Chinese Japanese
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Pharma & Bio
Lifestyle

Lunit Inc. and DRTECH Corporation Rise on Improved Earnings… Curiox Down 20% Amid Litigation Uncertainty [Bio Market Watch]

On the 13th, in the pharmaceutical and biotech sector, shares of Lunit Inc.(328130)and DRTECH Corporation(214680)rose in tandem, driven by improved earnings. Lunit Inc. attracted investor interest due…
  • 2026-11-16 07:42:02
  • Kim Jinsoo
Technology

Aston and Bertis Choose Their Path… They Started by Looking at Companies to Acquire in the Tech Sector

Even as it has become increasingly difficult for biotech startups to secure funding, there are venture capital (VC) firms that remain active in biotech investments. One such firm is Pathway Partners (…
  • 2026-11-16 07:21:02
  • NA EUN-KYUNG
Lifestyle

[Exclusive] From 25-Year Allies to Enemies… What Happened Between OSCOTEC Inc.’s Largest Shareholder and CEO? [OSCOTEC Inc. Conflict]

Even during the flight from Boston to Seoul—which lasted over 12 hours—he stayed awake all night, unable to sleep, and remained in constant contact. Although his day-night cycle was frequently disrupt…
  • 2026-11-16 07:01:02
  • Kim Jinsoo
Lifestyle

Rookie Baropharm and Embattled Moalife Plus Face Paradoxical Volatility as GC Genome Anchors the Market [K-Bio Pulse]

Amid broader market volatility on Thursday, South Korea’s biopharmaceutical sector lacked a clear directional trend, leaving traditional, profitable pharmaceutical and biotech firms to anchor investor…
  • 2026-11-14 12:47:03
  • YU JIN-HEE
Lifestyle

Newcomer BaroPharm and MoaLife in the Home Stretch Show Paradoxical ‘Hot Streak’... GC Genome Corporation Holds Steady [Bio Spotlight]

On the 12th, as the domestic securities market continued to show mixed trends and the biotech sector also failed to establish a clear direction, traditional pharmaceutical and biotech companies with s…
  • 2026-11-14 12:47:02
  • YU JIN-HEE
Technology

SK BIOPHARMACEUTICALS’ ‘Senobamate’ Sees Expansion of Indications for Children and Adolescents, but Hits a Snag in Europe... Why?

(Graphic: ChatGPT) Procedures are underway in Europe and the United States to expand the approved use of SK BIOPHARMACEUTICALS(326030)’s epilepsy treatment, cenobamate, to include children and ado…
  • 2026-11-14 07:31:02
  • Minji Son
Lifestyle

[Exclusive] Hwang Man-hoe, CEO of ADBIOTECH Co.,Ltd., Charged with Fraud and Obstruction of Business

ADBIOTECH Co.,Ltd.(179530), a KOSDAQ-listed company that had been seeking to improve its business fundamentals through management restructuring and business diversification, has become embroiled in a …
  • 2026-11-13 12:01:02
  • YU JIN-HEE
Technology

MedPacto Hits Limit-Up on Cancer Drug Data, Curiosis Rebounds on ODM Hopes [K-Bio Pulse]

On November 11, South Korean pharmaceutical, biotech, and healthcare stocks rose across the board amid a market rebound. MedPacto surged after preclinical findings for its cancer drug candidate MP010 …
  • 2026-11-13 07:37:04
  • Minji Son
Technology

MedPacto, Inc. Soars on Preclinical Results… Curiosis Inc. Also Rebounds on Global Business Expectations [Bio Spotlight]

On the 11th, domestic pharmaceutical, biotech, and healthcare stocks showed strength, buoyed by a general market rebound. MedPacto, Inc.(235980)is believed to have seen its stock price rise as expecta…
  • 2026-11-13 07:37:02
  • Minji Son
Lifestyle

“1 Billion Cells” AI Training Data: Psomagen, Inc.’s Share Grows

Psomagen, Inc.(950200) ’s role has expanded in a project by the Chan Zuckerberg Initiative (CZI)—founded by Mark Zuckerberg and Priscilla Chan—to train biological artificial intelligence (AI) using 1 …
  • 2026-11-13 06:41:02
  • KIM JI-WAN
1 2 3 4 5 6 7 8 9 10 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea China Japan
English